anticlotting

In another victory for an anticlotting drug co-developed by Bristol-Myers Squibb Co. and Pfizer Inc., U.S. regulators agreed to a speedy review of the companies' application to market it.

Stroke Drug to Get Speedy FDA Review Peter Loftus 2011

The priority review not only clears the way for an earlier-than-expected launch of Eliquis, whose active ingredient is called apixaban, but it is also a potential signal that the FDA views it as superior to other new anticlotting drugs, including Pradaxa from Boehringer Ingelheim GmbH and Xarelto from Johnson & Johnson and Bayer AG.

Stroke Drug to Get Speedy FDA Review Peter Loftus 2011

Roche lifted its full-year targets after posting better-than-expected first-half results, while AstraZeneca's shares jumped after U.S. drug regulators overnight approved its anticlotting drug Brilinta for sale in the world's largest market.

What's News 2011

The study compared Xarelto to an older anticlotting drug, warfarin.

Bayer, J&J Suffer FDA Setback Jennifer Corbett Dooren 2011

In London, AstraZeneca rose 2% after U.S. drug regulators approved its anticlotting drug Brilinta.

Europe Markets Surge on Steps Toward Debt Deal Andrea Tryphonides 2011

Roche Holding rose 1.3% after lifting its profit outlook following better-than-expected first-half results, while AstraZeneca rose 2% after U.S. drug regulators approved its anticlotting drug Brilinta.

Europe Markets Surge; Chinese Shares Skid Andrea Tryphonides 2011

Letters to the FDA from the groups—the Society of Hospital Medicine and the North American Thrombosis Forum—and the researcher, Victor Tapson , a thrombosis expert at Duke University, said that generic versions of Lovenox, a fast-acting anticlotting medicine, might not be as safe as the brand-name drug, according to the report.

Senate Panel Hits Sanofi Payments Alicia Mundy 2011

The European approval of Eliquis represents a much-needed victory for both companies' research-and-development efforts, as they face the losses of U.S. patent protection over the next year for their top-selling drugs: Pfizer's Lipitor cholesterol pill and Bristol's Plavix anticlotting drug.

E.U. Approves Blood Thinner From Bristol-Myers, Pfizer Peter Loftus 2011

LONDON—Shares in AstraZeneca PLC jumped in relief Thursday after U.S. drug regulators approved the British group's anticlotting drug Brilinta for sale in the world's largest market.

AstraZeneca Shares Rise on Drug's Approval Sten Stovall 2011

WASHINGTON—Food and Drug Administration staff recommended against an immediate approval for Johnson & Johnson and Bayer AG's anticlotting drug Xarelto as a treatment to prevent strokes in patients with atrial fibrillation.

Bayer, J&J Suffer FDA Setback Jennifer Corbett Dooren 2011